IP Library › Assignment 028232/0464
Patent Assignment
Reel/Frame 028232/0464

Security Agreement

Recorded: 2012-05-17 Pages: 17
Assignor
MERITAGE PHARMA, INC.
Executed: 2012-03-30
Assignee
TRIPLEPOINT CAPITAL LLC
2755 SAND HILL ROAD, MENLO PARK, CALIFORNIA, 94025
Covered Properties (6)
Compositions for the Treatment of Gastrointestinal Inflammation
Patent: 8,865,692 →
Application: 12/269,650 →
Publication: US 2009/0137540
Corticosteroid Compositions
Patent: 9,050,368 →
Application: 12/269,816 →
Publication: US 2009/0123550
Compositions for the Treatment of Inflammation of the Gastrointestinal Tract
Application: 12/762,222 →
Publication: US 2010/0216754
Methods for Treating Gastrointestinal Disorders
Application: 12/814,335 →
Publication: US 2011/0097401
Methods of Treatment for Esophageal Inflammation
Application: 61/483,580 →
Methods of Treatment for Esophageal Inflammation
Application: 13/168,601 →
Publication: US 2012/0164080
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 8, 2008
From: PHILLIPS, ELAINE; HILL, MALCOLM
To: MERITAGE PHARMA, INC.
Reel/Frame 021940/0644 →
Assignment of Assignor's Interest Dec 11, 2008
From: PHILLIPS, ELAINE; HILL, MALCOLM; LICALSI, CYNTHIA; DESHMUKH, HEMANT
To: MERITAGE PHARMA, INC.
Reel/Frame 021967/0819 →
Assignment of Assignor's Interest May 6, 2010
From: HILL, MALCOLM
To: MERITAGE PHARMA, INC.
Reel/Frame 024348/0409 →
Assignment of Assignor's Interest Oct 12, 2010
From: PHILLIPS, ELAINE; HILL, MALCOLM; SIMPSON, ADAM
To: MERITAGE PHARMA, INC.
Reel/Frame 025122/0923 →
Assignment of Assignor's Interest May 16, 2011
From: HILL, MALCOLM; PHILLIPS, ELAINE
To: MERITAGE PHARMA, INC.
Reel/Frame 026287/0290 →
Assignment of Assignor's Interest Jul 22, 2011
From: HILL, MALCOLM; PHILLIPS, ELAINE
To: MERITAGE PHARMA, INC.
Reel/Frame 026633/0759 →
Assignment of Assignor's Interest Aug 9, 2011
From: HILL, MALCOLM; PHILLIPS, ELAINE
To: MERITAGE PHARMA, INC.
Reel/Frame 026722/0456 →
Change of Address Jul 20, 2020
From: MERITAGE PHARMA, INC.
To: MERITAGE PHARMA, INC.
Reel/Frame 053256/0767 →
Merger Jul 9, 2021
From: MERITAGE PHARMA, INC.
To: SHIRE VIROPHARMA LLC
Reel/Frame 056802/0233 →
Merger Jul 9, 2021
From: SHIRE VIROPHARMA LLC
To: VIROPHARMA BIOLOGICS LLC
Reel/Frame 056802/0426 →